Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking

Screening already approved drugs for activity against a novel pathogen can be an important part of global rapid-response strategies in pandemics. Such high-throughput repurposing screens have already identified several existing drugs with potential to combat SARS-CoV-2. However, moving these hits fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribone, Sergio R., Paz, S. Alexis, Abrams, Cameron F., Villarreal, Marcos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616721/
https://www.ncbi.nlm.nih.gov/pubmed/34825285
http://dx.doi.org/10.1007/s10822-021-00432-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616721/
https://www.ncbi.nlm.nih.gov/pubmed/34825285
http://dx.doi.org/10.1007/s10822-021-00432-3

Ejemplares similares